The invention relates to a process for the manufacture of a compound of formula: (Formula I); or a salt, especially a pharmaceutically acceptable salt with a base, thereof or a lactone thereof wherein the element (a) represents --CH.sub.2--CH.sub.2-- or --CH.dbd.CH-- and R represents a cyclic radical. ##STR00001##

 
Web www.patentalert.com

> Estrogen agonist/antagonist metabolites

~ 00341